Pfizer and BioNTech Begin Human Clinical Trials of COVID-19 Vaccine in US

The first human clinical trials for Pfizer’s and BioNTech’s experimental COVID-19 vaccine, BNT162, have begun in the U.S. The vaccine is undergoing an accelerated trial process that Pfizer’s CEO Albert Bourla called “extraordinary.” Four different versions of the vaccine, which uses messenger RNA (mRNA), will be administered to the volunteer subjects. According to researchers at University of Pennsylvania and Duke University, mRNA vaccines have potential...

Read the Full Article for Free!

You can unsubscribe at any time and I guarantee the privacy of your email. View our privacy policy

Subscribe for FREE to the #1 Natural Health Newsletter or Login for Instant Access

Unlock censored health information that Google doesn't want you to read

Keep your privacy secure — we are one of the few websites that have banned all Google and Facebook scripts to help stop their surveillance capitalism

Get access to all of Dr. Mercola's health articles, E-books and special reports